Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TipA (Thiostrepton-inducible protein A) family regulatory proteins are specialized bacterial transcription factors, most notably characterized in Streptomyces species such as Streptomyces lividans [UniProt: P14191]. These proteins function as molecular sensors for thiopeptide antibiotics, including thiostrepton and nosiheptide, which trigger a robust transcriptional response upon binding [PubMed: 2127164]. The family typically includes two isoforms: TipAL, a full-length transcriptional activator, and TipAS, a truncated version that lacks the DNA-binding domain but retains high affinity for the antibiotic inducer [PubMed: 10490112]. When a thiopeptide molecule binds to the C-terminal domain of TipAL, it induces a conformational change that allows the N-terminal MerR-like helix-turn-helix domain to bind to specific operator sequences, thereby initiating the expression of genes involved in antibiotic resistance [PubMed: 15659714]. While TipA is not a direct target for treating human diseases, it is a vital tool in biotechnology for inducible gene expression systems and serves as a model for studying bacterial signal transduction and resistance mechanisms [PubMed: 11722394]. Its high specificity for thiopeptides makes it a unique example of a protein-based antibiotic sensor that coordinates the bacterial response to environmental chemical threats.
Thiopeptide antibiotic binding to the C-terminal domain of the TipAL protein induces a conformational change in the N-terminal DNA-binding domain, which increases its affinity for specific operator sequences and activates the transcription of target genes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiostrepton-inducible protein A family regulatory protein (TipA).